Y. Sookrajh

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

Sheena McCormack, Helen Rees, Heiner Grosskurth, 2010, The Lancet.